会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Factor VII fragment 82-128 and its use in blood-clotting disorders
    • 因子VII片段82-128及其在血液凝固疾病中的应用
    • US5948759A
    • 1999-09-07
    • US849248
    • 1997-08-27
    • Mette HusbynPeter FischerLars Orning
    • Mette HusbynPeter FischerLars Orning
    • C12N15/09A61K38/00A61K38/43A61P7/02A61P9/08A61P9/10C07K14/745C12N9/64A61K38/17A61K38/36C07K14/435
    • C12N9/6437C12Y304/21021A61K38/00Y10S514/822
    • The present invention relates to peptide of the amino acid sequence of formula (I): 82 85 90 Glu Thr His Lys Asp Asp Gln Leu Ile 95 100 Cys Val Asn Glu Asn Gly Gly Cys Glu Gln 105 110 Tyr Cys Ser Asp His Thr Gly Thr Lys Arg 115 120 Ser Cys Arg Cys His Glu Gly Tyr Ser Leu 125 128 Leu Ala Asp Gly Val Ser Cys Thr (SEQ ID NO. 1) and functional equivalents thereof in which amino acids in the above stated sequence are modified or absent and wherein at least one of the cysteine residues may be blocked or replaced and wherein any cysteine residues which remain unblocked or unreplaced may be present in a disulphide bonded state. The invention also includes slats and derivatives of said peptides. The peptides and their salts and derivatives are useful in the treatment of blood clotting disorders.
    • PCT No.PCT / GB95 / 02946 Sec。 371日期1997年8月27日第 102(e)日期1997年8月27日PCT提交1995年12月15日PCT公布。 公开号WO96 / 18654 日期:1996年6月20日本发明涉及式(I)的氨基酸序列的肽: - 82 85 90 - Glu Thr His Lys Asp Asp Gln Leu Ile - - 95 100 - Cys Val Asn Glu Asn Gly Gly Cys Glu Gln - - 105 110 - Tyr Cys Ser Asp His Thr Gly Thr Lys Arg - - 115 120 - Ser Cys Arg Cys His Glu Gly Tyr Ser Leu - - 125 128 - Leu Ala Asp Gly Val Ser Cys Thr(SEQ ID NO.1 )和其功能等同物,其中上述序列中的氨基酸被修饰或不存在,并且其中至少一个半胱氨酸残基可被阻断或替换,并且其中保持未阻断或未置换的任何半胱氨酸残基可以存在于二硫键中 州。 本发明还包括所述肽的板条和衍生物。 肽及其盐和衍生物可用于治疗凝血障碍。